oxantel Report issue

Small molecule Experimental
AACT ChEMBL Drug Central MeSH PubChem

Active Ingredient History

NOW
  • Now
Oxantel is an anthelmintic. It has typically been used in human and animal medicine as a treatment for intestinal worms. It has also been shown to inhibit fumarate reductase in some pathogenic bacteria.   Wikipedia

Chemistry

  • SMILES: CN1CCCN=C1/C=C/c1cccc(O)c1
  • InChIKey: VRYKTHBAWRESFI-VOTSOKGWSA-N
  • Mol. Mass: 216.28
  • ALogP: 2.14
  • ChEMBL Molecule:
    oxantel  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

1,4,5,6-tetrahydro-2-(3-hydroxy styryl)-1-methylpyrimidine | cp 14,445 | cp-14,445 | oxantel | oxantel monohydrochloride, (e)-isomer | oxantel tartrate | oxantel tartrate (1:1), (r-(r*,r*))-isomer

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (4)

Approved Indications (1)


 

Ascaris

Experimental Indications - Clinical Trial Phases 1-4 (3)


 

Helminthiasis ()

Hookworm Infections (Phase 4)

Trichuris (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue